Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Preclinical to Human Translational Pharmacology of the Novel M1 Positive Allosteric Modulator MK-7622 - Uslaner_2018_J.Pharmacol.Exp.Ther_365_556 |
| Author(s) : Uslaner JM , Kuduk SD , Wittmann M , Lange HS , Fox SV , Min C , Pajkovic N , Harris D , Cilissen C , Mahon C , Mostoller K , Warrington S , Beshore DC |
| Ref : Journal of Pharmacology & Experimental Therapeutics , 365 :556 , 2018 |
| Abstract : Uslaner_2018_J.Pharmacol.Exp.Ther_365_556 |
| ESTHER : Uslaner_2018_J.Pharmacol.Exp.Ther_365_556 |
| PubMedSearch : Uslaner_2018_J.Pharmacol.Exp.Ther_365_556 |
| PubMedID: 29563325 |
| Title : Odanacatib, a selective cathepsin K inhibitor, demonstrates comparable pharmacodynamics and pharmacokinetics in older men and postmenopausal women - Anderson_2014_J.Clin.Endocrinol.Metab_99_552 |
| Author(s) : Anderson MS , Gendrano IN , Liu C , Jeffers S , Mahon C , Mehta A , Mostoller K , Zajic S , Morris D , Lee J , Stoch SA |
| Ref : J Clinical Endocrinology Metab , 99 :552 , 2014 |
| Abstract : Anderson_2014_J.Clin.Endocrinol.Metab_99_552 |
| ESTHER : Anderson_2014_J.Clin.Endocrinol.Metab_99_552 |
| PubMedSearch : Anderson_2014_J.Clin.Endocrinol.Metab_99_552 |
| PubMedID: 24276460 |